Search Results Search Sort by RelevanceMost Recent Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 1 Lofty L. Basta, MD Virtual Mentor. 2007;9(2):91-96. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702. Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 2 Katrina A. Bramstedt, PhD Virtual Mentor. 2007;9(2):96-98. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):-. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501. Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 1 Jim Kirkpatrick, MD Virtual Mentor. 2002;4(6):159-163. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206. Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 2 Erin Egan, MD, JD and Kayhan Parsi, JD, PhD Virtual Mentor. 2002;4(6):164-168. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206. Case and Commentary Jan 2005 Respect for Patient Decision Making: Mr. Douglas's Choice of Treatment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5-0501. Case and Commentary Jan 2005 Surrogate Decision Making: Mrs. Douglas's Choice of Treatment for Her Husband Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7-0501. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 1 Lofty L. Basta, MD Virtual Mentor. 2007;9(2):91-96. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702.
Case and Commentary Feb 2007 Turning Off an Implanted Life-Saving Device, Commentary 2 Katrina A. Bramstedt, PhD Virtual Mentor. 2007;9(2):96-98. doi: 10.1001/virtualmentor.2007.9.2.ccas2-0702.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):-. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501.
Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 1 Jim Kirkpatrick, MD Virtual Mentor. 2002;4(6):159-163. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206.
Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 2 Erin Egan, MD, JD and Kayhan Parsi, JD, PhD Virtual Mentor. 2002;4(6):164-168. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206.
Case and Commentary Jan 2005 Respect for Patient Decision Making: Mr. Douglas's Choice of Treatment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5-0501.
Case and Commentary Jan 2005 Surrogate Decision Making: Mrs. Douglas's Choice of Treatment for Her Husband Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7-0501.